Completed PHASE4 INTERVENTIONAL 2-arm NCT01281501

Symptomatic Relief of Acute Dyspeptic Pain in Emergency Department With Pantoprazole

A Randomized, Controlled Trial of Adding Intravenous Pantoprazole to Conventional Treatment for the Immediate Relief of Dyspeptic Pain

Sponsor: Chulalongkorn University

Conditions Dyspepsia Emergency Pain

Interventions Hyoscine butylbromide Normal saline Oral antacid Pantoprazole

Updated 11 times since 2017 Last updated: Sep 9, 2013 Started: Jan 31, 2011 Primary completion: Oct 31, 2011 Completion: Oct 31, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Dyspepsia and Emergency and is currently completed. Chulalongkorn University leads this study, which shows 11 recorded versions since 2011 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

11 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE4
Sep 2024 — Sep 2025 [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2023 — Jul 2024 [monthly]

Completed PHASE4
Dec 2022 — Jan 2023 [monthly]

Completed PHASE4

▶ Show 6 earlier versions

Dec 2021 — Dec 2022 [monthly]

Completed PHASE4
Jan 2021 — Dec 2021 [monthly]

Completed PHASE4
Sep 2020 — Jan 2021 [monthly]

Completed PHASE4
Jun 2018 — Sep 2020 [monthly]

Completed PHASE4
Feb 2017 — Jun 2018 [monthly]

Completed PHASE4
Jan 2017 — Feb 2017 [monthly]

Completed PHASE4

First recorded

Jan 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Chulalongkorn University

Data source: Chulalongkorn University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Patumwan, Thailand